---
title: "Pre-market hot trades in US stocks: Infobird pre-market down 7.81%; Werewolf Therapeutics pre-market up 7.22%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258718057.md"
description: "Infobird pre-market down 7.81%; Werewolf Therapeutics pre-market up 7.22%; SHF pre-market up 181.60%; uniQure pre-market up 158.57%; Lithium Americas pre-market up 65.47%"
datetime: "2025-09-24T13:12:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258718057.md)
  - [en](https://longbridge.com/en/news/258718057.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258718057.md)
---

# Pre-market hot trades in US stocks: Infobird pre-market down 7.81%; Werewolf Therapeutics pre-market up 7.22%

**Pre-market Hot Trades in US Stocks**

**Top Gainers in Pre-market US Stocks**

uniQure is up 158.57% in pre-market trading. Based on recent key news:

1.  On September 24, uniQure announced that its experimental gene therapy AMT-130 significantly slowed the progression of a brain disease in early to mid-stage trials. The therapy reduced disease progression by 75% over 36 months, leading to a substantial increase in stock price.
    
2.  On September 24, uniQure announced the refinancing of its existing $50 million debt and secured up to $125 million in non-dilutive funding. This enhanced the company's financial flexibility, further driving up the stock price.
    
3.  On September 24, uniQure's CFO stated that the company is preparing for a potential commercial launch of AMT-130 in the US in 2026, boosting market confidence. The gene therapy industry has shown strong recent performance, with significant capital inflows.
    

Lithium Americas is up 65.47% in pre-market trading. Based on recent important news:

1.  On September 24, the US government plans to restructure Lithium Americas' $2.3 billion loan through equity investment, causing the company's stock price to surge nearly 90% in after-hours trading. This move is seen as a significant measure to enhance market confidence in the company's financing and project advancement.
    
2.  On September 24, Reuters reported that the Trump administration seeks to hold up to 10% equity in Lithium Americas to renegotiate the loan terms for the Thacker Pass lithium mine project, promoting a strategic layout for the supply chain of critical minerals for US new energy.
    
3.  On September 24, Lithium Americas continued negotiations with the US Department of Energy and General Motors regarding the financing conditions for the Thacker Pass project, with the market full of expectations for the project's advancement. The lithium mining industry is experiencing increased volatility driven by policy support

### Related Stocks

- [IFBD.US](https://longbridge.com/en/quote/IFBD.US.md)
- [HOWL.US](https://longbridge.com/en/quote/HOWL.US.md)

## Related News & Research

- [Werewolf Therapeutics posts Q2 profit on Jazz asset sale](https://longbridge.com/en/news/294503550.md)
- [Werewolf Therapeutics director Luke Evnin disposes of 157,084 common shares for $47,125.2](https://longbridge.com/en/news/291197756.md)
- [RA Capital Management disposes of Werewolf Therapeutics shares worth $145,069](https://longbridge.com/en/news/290485642.md)
- [Luke Evnin Sells 22,184 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock](https://longbridge.com/en/news/287219594.md)
- [Werewolf Reports Q1 Loss Of $13 Mln, Highlights Asset Purchase Agreement With Jazz](https://longbridge.com/en/news/285710502.md)